Literature DB >> 28529339

Glomerular disease: Updated Oxford Classification of IgA nephropathy: a new MEST-C score.

Glen Markowitz1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28529339     DOI: 10.1038/nrneph.2017.67

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  The MEST score provides earlier risk prediction in lgA nephropathy.

Authors:  Sean J Barbour; Gabriela Espino-Hernandez; Heather N Reich; Rosanna Coppo; Ian S D Roberts; John Feehally; Andrew M Herzenberg; Daniel C Cattran
Journal:  Kidney Int       Date:  2016-01       Impact factor: 10.612

Review 2.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Authors:  Hernán Trimarchi; Jonathan Barratt; Daniel C Cattran; H Terence Cook; Rosanna Coppo; Mark Haas; Zhi-Hong Liu; Ian S D Roberts; Yukio Yuzawa; Hong Zhang; John Feehally
Journal:  Kidney Int       Date:  2017-03-22       Impact factor: 10.612

Review 3.  Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.

Authors:  Jicheng Lv; Sufang Shi; Damin Xu; Hong Zhang; Stéphan Troyanov; Daniel C Cattran; Haiyan Wang
Journal:  Am J Kidney Dis       Date:  2013-06-29       Impact factor: 8.860

4.  Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.

Authors:  Rupali S Avasare; Paul E Rosenstiel; Ziad S Zaky; Demetra S Tsapepas; Gerald B Appel; Glen S Markowitz; Andrew S Bomback; Pietro A Canetta
Journal:  Am J Nephrol       Date:  2017-01-06       Impact factor: 3.754

5.  Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

Authors:  Shubha S Bellur; Fanny Lepeytre; Olga Vorobyeva; Stéphan Troyanov; H Terence Cook; Ian S D Roberts
Journal:  Kidney Int       Date:  2016-12-01       Impact factor: 10.612

6.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

7.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Authors:  Daniel C Cattran; Rosanna Coppo; H Terence Cook; John Feehally; Ian S D Roberts; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Chi Bon Leung; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

8.  A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Authors:  Mark Haas; Jacobien C Verhave; Zhi-Hong Liu; Charles E Alpers; Jonathan Barratt; Jan U Becker; Daniel Cattran; H Terence Cook; Rosanna Coppo; John Feehally; Antonello Pani; Agnieszka Perkowska-Ptasinska; Ian S D Roberts; Maria Fernanda Soares; Hernan Trimarchi; Suxia Wang; Yukio Yuzawa; Hong Zhang; Stéphan Troyanov; Ritsuko Katafuchi
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

9.  Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.

Authors:  James A Tumlin; R A Hennigar
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

10.  Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan.

Authors:  Takahito Moriyama; Kayu Tanaka; Chihiro Iwasaki; Yasuko Oshima; Ayami Ochi; Hiroshi Kataoka; Mitsuyo Itabashi; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

  10 in total
  10 in total

1.  The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.

Authors:  Neal B Shah; Sagar U Nigwekar; Sahir Kalim; Benjamin Lelouvier; Florence Servant; Monika Dalal; Scott Krinsky; Alessio Fasano; Nina Tolkoff-Rubin; Andrew S Allegretti
Journal:  Kidney360       Date:  2021-06-09

2.  Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.

Authors:  Qi Chen; Zi Wang; Jicheng Lv; Lijun Liu; Hang Li; Weiwei Sun; Yanhong Huo; Yingbo Guo; Cun Shen; Shichao Li; Zhenjie Chen; Jingwei Zhou
Journal:  Trials       Date:  2022-05-25       Impact factor: 2.728

3.  Tonsillitis exacerbates renal injury in IgA nephropathy through promoting Th22 cells chemotaxis.

Authors:  Lu Gan; Mengyuan Zhu; Xiaozhao Li; Chen Chen; Ting Meng; Jiaxi Pu; Huiming Luo; Fengmin Shao; Qiaoling Zhou
Journal:  Int Urol Nephrol       Date:  2018-03-16       Impact factor: 2.370

4.  Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.

Authors:  Jie Wei; Yan Wang; Xiangming Qi; Yonggui Wu
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

5.  Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study.

Authors:  Lingzhi Wu; Di Liu; Ming Xia; Guochun Chen; Yu Liu; Xuejing Zhu; Hong Liu
Journal:  BMC Nephrol       Date:  2021-01-29       Impact factor: 2.388

6.  Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy.

Authors:  Yun-Ting Juan; Wen-Chih Chiang; Wei-Chou Lin; Cheng-Wen Yang; San-Fang Chou; Ruo-Wei Hung; Yen-Ling Chiu
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

7.  The Association of the Oxford Classification Score with Longitudinal Estimated Glomerular Filtration Rate Decline in Patients with Immunoglobulin A Nephropathy: A Mixed-Method Study.

Authors:  Ricong Xu; Zhijian Li; Tao Cao; Yi Xu; Ying Liao; Haiying Song; Xiaojie Chen; Fei Tang; Qiong Xiang; Qijun Wan
Journal:  Int J Gen Med       Date:  2021-06-18

8.  Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis.

Authors:  Jiaxing Tan; Yicong Xu; Zheng Jiang; Gaiqin Pei; Yi Tang; Li Tan; Zhengxia Zhong; Padamata Tarun; Wei Qin
Journal:  Front Med (Lausanne)       Date:  2020-10-23

Review 9.  Massive hemorrhage after percutaneous kidney biopsy caused by renal artery malformation: a case report and literature review.

Authors:  Dong Liang; Hui Zhang; Min Yang; Hong Ji; Gang Chen; Ning Yu; Xiaomin Zhang
Journal:  BMC Surg       Date:  2020-10-29       Impact factor: 2.102

10.  The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study.

Authors:  Mengjun Liang; Liping Xiong; Aihua Li; Jiafan Zhou; Yajuan Huang; Miaofang Huang; Xing Zhang; Hongrui Shi; Ning Su; Yi Wei; Zongpei Jiang
Journal:  BMC Nephrol       Date:  2022-01-21       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.